Syndax Pharmaceuticals Stock (NASDAQ: SNDX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.054M |
Day Range | - - - |
52 Wk Range | 11.215 - 25.340 |
Market Cap | $1.599B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 11.9% |
Days to Cover | 10.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Syndax Pharmaceuticals (NASDAQ: SNDX) through any online brokerage.
Other companies in Syndax Pharmaceuticals’s space includes: Fusion Pharmaceuticals (NASDAQ:FUSN), Xencor (NASDAQ:XNCR), Protagonist Therapeutics (NASDAQ:PTGX), Kiniksa Pharmaceuticals (NASDAQ:KNSA) and Bicycle Therapeutics (NASDAQ:BCYC).
The latest price target for Syndax Pharmaceuticals (NASDAQ: SNDX) was reported by JP Morgan on Tuesday, May 21, 2024. The analyst firm set a price target for 34.00 expecting SNDX to rise to within 12 months (a possible 80.66% upside). 28 analyst firms have reported ratings in the last year.
The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $18.82 last updated June 4, 2024 at 4:56 PM EDT.
There are no upcoming dividends for Syndax Pharmaceuticals.
Syndax Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Syndax Pharmaceuticals.
Syndax Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.